European Journal of Medical Case Reports (EJMCR) will consider any original case report that adds new information to existing general medical knowledge, and original research relating to case reports in all medical disciplines.
EJMCR also accepts videos related to the case reports.
(EJMCR is a not-for-profit journal. We follow ethical publishing practices as recommended by COPE. We don't have any fast-track publication service upon extra payment.)
University Hospital for Trauma and Orthopaedic Surgery, Pius Hospital, Carl-von- Ossietzky University Oldenburg, Germany.
Director, Department of Nuclear Medicine, Pius-Hospital, Oldenburg, Germany. Medical Faculty of the Rheinische Friedrich-Wilhelms-University Bonn, Germany
EJMCR Associate Editor, Consultant Paediatric Neurologist & Clinical lead for Complex Movement Disorders Service. Royal Bristol Hospital for Children, University of Bristol, Bristol, United Kingdom
Professor of Nuclear Medicine and Oncology at Medical School, Padova University, Italy.Member of experts committee of the Ministry of Health, Spain and Ministry of Health, France, for the revision of scientific projects to be funded
Assistant Professor Nuclear Medicine Research Center Mashhad University of Medical Sciences, Iran
Although every effort is made by the Editorial Board of the concerned journals and the publisher (Discover Publishing Group) to see that no inaccurate or misleading data, opinion or statement appear in the journal(s) or websites managed or published by Discover Published Group, we want to make it clear that the data and opinions appearing in the articles and advertisements herein are the responsibility of the contributors, sponsors, or advertisers concerned. Accordingly, the Publisher and the Editorial Boards disclaim all responsibilities for the consequences of any such inaccurate or misleading data, opinion, or statement. To the extent permissible under applicable laws, no responsibility is assumed by the Publisher nor by the Editors for any injury and/or damage to persons or property as a result of any actual or alleged libellous statements, infringement of intellectual property or privacy rights, or products liability, whether resulting from negligence or otherwise, or from any use or operation of any ideas, instructions, procedures, products or methods contained in the material therein. Whilst every effort is made to ensure that drug doses and other quantities are presented accurately, readers are advised that new methods and techniques involving drug usage, and described in DPG journals, should only be followed in conjunction with the drug manufacturer’s own published literature in their own country.